Logo Image
News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademyShortsSponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Events
Webcasts
Event Calendar

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Events
  • Subscribe
  • Event Calendar
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
Clinical Operations & Strategy|
Patient Participation
Advertisement
|Articles|March 20, 2012

Inside the EU's Next Generation of Pharmacovigilance

Advertisement
External Link - article-765264.pdf

Advertisement

Related Content

Advertisement

When the Slack Runs Out: AI and the CRO Operating Model

ByJoanna Williams
August 21st 2026

What Needs to Be True Across Sponsors, Sites, and Regulators for Operation TrialBlazer to Succeed

ByAmber Hill, PhD,Andy Studna, Senior Editor
August 21st 2026

ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment

ByAndy Studna, Senior Editor
August 21st 2026
© tippapatt - © tippapatt - stock.adobe.com

Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations

ByAndy Studna, Senior Editor
August 20th 2026

Where AI Has the Most Immediate Impact in Phase I Execution

ByAmber Hill, PhD,Andy Studna, Senior Editor
August 20th 2026
Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations

2

ACT Brief: AI Architecture and Model Ownership Due Diligence, FDA Framework for Generative AI Medical Devices, and Heidi Overton Nominated for FDA Commissioner

3

Syneos Health Expands AI Ecosystem With Three New Platform Partnerships

4

FDA Seeks Public Input on Regulatory Framework for Generative AI-Enabled Medical Devices

5

One Clinical: Working Together to Advance Trial Collaboration

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us